Communiqués InMode Ltd.

Actions

INMD

IL0011595993

Equipement et technologie médicale avancés

Marché Fermé - 22:00:00 21/08/2026 Varia. 5j. Varia. 1 janv.
15,06 USD +0,94% Graphique intraday de InMode Ltd. -0,59% +2,52%

Communiqués

05/08 InMode: Q2 Earnings Snapshot AQ
06/05 InMode: Q1 Earnings Snapshot AQ
24/04 InMode Ltd. V. BTL Industries, Inc. (D. Mass. 24-cv-12955). AQ
24/03 InMode to Present at the 25th Annual Needham Virtual Healthcare Conference PR
13/03 InMode Announces New Share Repurchase Program PR
10/02 Lumecca IPL in Los Angeles: Modern Photorejuvenation With Enhanced Cooling Technology AQ
10/02 InMode : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F) PU
10/02 InMode: Q4 Earnings Snapshot AQ
10/02 InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million PR
03/02 InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference PR
02/02 InMode Responds to Transaction Rumors PR
08/01 InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M PR
05/11 InMode: Q3 Earnings Snapshot AQ
03/11 InMode Appoints Michael Dennison as President of North America PR
30/10/25 InMode to Participate in Upcoming Investor Conferences PR
09/09/25 DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders PR
02/09/25 InMode to Present at Baird 2025 Global Healthcare Conference PR
05/08/25 InMode to Participate in Upcoming Investor Conferences PR
30/07/25 InMode: Q2 Earnings Snapshot AQ
30/07/25 InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins PR
10/07/25 InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M PR
28/05/25 InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 PR
20/05/25 InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology AQ
16/05/25 Keys Med Spa Receives Morpheus8 Top Provider Award from Inmode AQ
09/05/25 DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program PR
Aucun résultat pour cette recherche